BPA Call W81XWH19A0008-HT942523F0111
Award Date
4/1/23
Potential Completion Date
4/1/23
Potential Value
$52K
Federal Agency
Defense Health Agency
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call contract to Gen-Probe Incorporated, a medical diagnostics company, for the PANTHER FUSION STANDARD SERVICE. The $56,000.00 contract has an ultimate completion date of March 31, 2025. Gen-Probe Incorporated has provided various medical diagnostic tests and equipment, such as APTIMA assays for infectious diseases and PANTHER FUSION systems, to federal agencies including the Defense Health Agency,...
This firm-fixed-price purchase order, valued at $122,500.00, was awarded by the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for a service agreement to provide the PANTHER FUSION System. The contract has no set-aside designation and an ultimate completion date of May 19, 2027. Gen-Probe is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Defense Health...
This is a firm fixed-price delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for PANTHER EQUIPMENT AND TEST KITS. The potential value of the contract is $539,000.00. There was no set-aside designation used for this award. Gen-Probe Incorporated has provided a variety of medical testing products and services to federal agencies in the past, including APTIMA assays for infectious diseases, PANTHER FUSION systems,...
This federal contract award is for PANTHER EQUIPMENT AND TEST KITS, delivered by Gen-Probe Incorporated, a medical diagnostics company, to the U.S. Department of Defense's Medical Command. The $659,000.00 Firm Fixed Price Delivery Order contract has an ultimate completion date of September 30, 2020. Gen-Probe has held numerous federal contracts to provide medical diagnostic products and services, including molecular testing systems, assays, and supplies for detecting infectious diseases like...
This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The $650,000 contract is for reagents rental to support the agency's diagnostic testing requirements. The award is not set aside and is part of a larger indefinite delivery vehicle established by DHA in January 2022 with a $15 million ceiling for COVID-19 testing services and supplies. Gen-Probe has held numerous federal contracts...
This federal contract award, valued at $25,000.00, was issued by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of PANTHER COVID-19 testing supplies. The contract is a purchase order with a firm fixed price and does not have a set-aside designation. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Department of Defense,...
The Department of the Army Medical Command awarded a $52,972.60 firm fixed price call against its PANTHER FUSION STANDARD blanket purchase agreement to Gen-Probe Incorporated on March 4, 2021. Performance will take place in Marlborough, Massachusetts through March 31, 2022. Gen-Probe Sales & Service, Inc. will deliver products or services in support of the Army Medical Command's medical equipment and supply needs. No set-aside provisions were specified for this particular call under the...
The Department of the Army Medical Command awarded Gen-Probe Incorporated, a medical diagnostics company, a $330,000.00 firm fixed price purchase order for the PANTHER INSTRUMENT SYSTEM. This contract is not set aside and is related to the Coronavirus COVID-19 national interest action. Gen-Probe Incorporated has previously provided a variety of medical testing systems and assays, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans...
This is a delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for the provision of PANTHER SYSTEM REAGENTS. The contract is a Firm Fixed Price contract with a potential value of $288,636.32 and a completion date of September 30, 2022. The contract does not have a set-aside designation. Gen-Probe Incorporated has a history of providing a variety of medical diagnostic tests and equipment, such as assays for...
Gen-Probe Incorporated, operating through its division Gen-Probe Sales & Service, Inc., has been awarded a $49,000 firm fixed price call against the PANTHER FUSION STANDARD SERVICE blanket purchase agreement by the Department of the Army Medical Command. Under this contract, Gen-Probe will provide maintenance and support services for two PANTHER FUSION diagnostic systems located in Marlborough, Massachusetts through March 2023. The PANTHER FUSION is an automated molecular diagnostic platform...